Premium
Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I‐Preserve)
Author(s) -
Böhm Michael,
Perez AnaCristina,
Jhund Pardeep S.,
Reil Jan C.,
Komajda Michel,
Zile Michael R.,
McKelvie Robert S,
Anand Inder S,
Massie Barry M.,
Carson Peter E.,
McMurray John J. V.
Publication year - 2014
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.85
Subject(s) - medicine , heart failure , cardiology , ejection fraction , atrial fibrillation , irbesartan , sinus rhythm , heart rate , blood pressure
Higher heart rate is associated with poorer outcomes in patients with heart failure and reduced ejection fraction (HF-REF). Less is known about the association between heart rate and outcomes in patients with heart failure and preserved ejection fraction (HF-PEF). Therefore, we examined the relationship between heart rate and outcomes in the irbesartan in patients with heart failure and preserved systolic function trial (I-Preserve) in patients with an ejection fraction >45% aged >60 years.